|
1
|
Felix AS and Brinton LA: Cancer progress
and priorities: Uterine cancer. Cancer Epidemiol Biomarkers Prev.
27:985–994. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sheikh MA, Althouse AD, Freese KE, Soisson
S, Edwards RP, Welburn S, Sukumvanich P, Comerci J, Kelley J,
LaPorte RE and Linkov F: USA endometrial cancer projections to
2030: Should we be concerned? Future Oncol. 10:2561–2568. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McAlpine JN, Temkin SM and Mackay HJ:
Endometrial cancer: Not your grandmother's cancer. Cancer.
122:2787–2798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simmen RC, Pabona JM, Velarde MC, Simmons
C, Rahal O and Simmen FA: The emerging role of Krüppel-like factors
in endocrine-responsive cancers of female reproductive tissues. J
Endocrinol. 204:223–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simmen RCM, Heard ME, Simmen AM, Montales
MT, Marji M, Scanlon S and Pabona JM: The Krüppel-like factors in
female reproductive system pathologies. J Mol Endocrinol.
54:R89–R101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diakiw SM, D'Andrea RJ and Brown AL: The
double life of KLF5: Opposing roles in regulation of
gene-expression, cellular function, and transformation. IUBMB Life.
65:999–1011. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nandan MO, McConnell BB, Ghaleb AM,
Bialkowska AB, Sheng H, Shao J, Babbin BA, Robine S and Yang VW:
Krüppel-like factor 5 mediates cellular transformation during
oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology.
134:120–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marrero-Rodríguez D, Taniguchi-Ponciano K,
Jimenez-Vega F, Romero-Morelos P, Mendoza-Rodríguez M, Mantilla A,
Rodriguez-Esquivel M, Hernandez D, Hernandez A, Gomez-Gutierrez G,
et al: Krüppel-like factor 5 as potential molecular marker in
cervical cancer and the KLF family profile expression. Tumor Biol.
35:11399–11407. 2014. View Article : Google Scholar
|
|
11
|
Zheng HQ, Zhou Z, Huang J, Chaudhury L,
Dong JT and Chen C: Krüppel-like factor 5 promotes breast cell
proliferation partially through upregulating the transcription of
fibroblast growth factor binding protein 1. Oncogene. 28:3702–3713.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meyer SE, Hasenstein JR, Baktula A, Velu
CS, Xu Y, Wan H, Whitsett JA, Gilks CB and Grimes HL: Kruppel-like
factor 5 is not required for K-RasG12D lung tumorigenesis, but
represses ABCG2 expression and is associated with better
disease-specific survival. Am J Pathol. 177:1503–1513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Bhalala HV, Vessella RL and Dong
JT: KLF5 is frequently deleted and down-regulated but rarely
mutated in prostate cancer. Prostate. 55:81–88. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi H, Zhang Z, Wang X, Liu S and Teng CT:
Isolation and characterization of a gene encoding human
Kruppel-like factor 5 (IKLF): Binding to the CAAT/GT box of the
mouse lactoferrin gene promoter. Nucleic Acids Res. 27:4807–4815.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun X, Zhang L, Xie H, Wan H, Magella B,
Whitsett JA and Dey SK: Kruppel-like factor 5 (KLF5) is critical
for conferring uterine receptivity to implantation. Proc Natl Acad
Sci USA. 109:1145–1150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stewart SA, Dykxhoorn DM, Palliser D,
Mizuno H, Yu EY, An DS, Sabatini DM, Chen ISY, Hahn WC, Sharp AP,
et al: Lentivirus-delivered stable gene silencing by RNAi in
primary cells. RNA. 9:493–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nandan MO, Chanchevalap S, Dalton WB and
Yang VW: Krüppel-like factor 5 promotes mitosis by activating the
cyclin B1/Cdc2 complex during oncogenic Ras-mediated
transformation. FEBS Lett. 579:4757–4762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nandan MO, Yoon HS, Zhao W, Ouko LA,
Chanchevalap S and Yang VW: Krüppel-like factor 5 mediates the
transforming activity of oncogenic H-Ras. Oncogene. 23:3404–3413.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McConnell BB, Bialkowska AB, Nandan MO,
Ghaleb AM, Gordon FJ and Yang VW: Haploinsufficiency of
Krüppel-like factor 5 rescues the tumor-initiating effect of the
Apc(Min) mutation in the intestine. Cancer Res. 69:4125–4133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nandan MO, Ghaleb AM, McConnell BB, Patel
NV, Robine S and Yang VW: Krüppel-like factor 5 is a crucial
mediator of intestinal tumorigenesis in mice harboring combined
ApcMin and KRASV12 mutations. Mol Cancer. 9:632010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takagi Y, Sakai N, Yoshitomi H, Furukawa
K, Takayashiki T, Kuboki S, Takano S, Suzuki D, Kagawa S, Mishimi
T, et al: High expression of Krüppel-like factor 5 is associated
with poor prognosis in patients with colorectal cancer. Cancer Sci.
111:2078–2092. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng TH, Thompson DJ, O'Mara TA, Painter
JN, Glubb DM, Flach S, Lewis A, French JD, Freeman-Mills L, Church
D, et al: Five endometrial cancer risk loci identified through
genome-wide association analysis. Nat Genet. 48:667–674. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pattison JM, Posternak V and Cole MD:
Transcription factor KLF5 binds a cyclin E1 polymorphic intronic
enhancer to confer increased bladder cancer risk. Mol Cancer Res.
14:1078–1086. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakayama K, Rahman MT, Rahman M, Nakamura
K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N
and Kyo S: CCNE1 amplification is associated with aggressive
potential in endometrioid endometrial carcinomas. Int J Oncol.
48:506–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Santala S, Talvensaari-Mattila A, Soini Y
and Santala M: Cyclin E expression correlates with cancer-specific
survival in endometrial endometrioid adenocarcinoma. Anticancer
Res. 35:3393–3397. 2015.PubMed/NCBI
|
|
27
|
Du JX, Bialkowska AB, McConnell BB and
Yang VW: SUMOylation regulates nuclear localization of Krüppel-like
factor 5. J Biol Chem. 283:31991–32002. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z and Teng CT: Phosphorylation of
Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region
enhances its transactivation function. Nucleic Acids Res.
31:2196–2208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu N, Gu L, Findley HW, Chen C, Dong JT,
Yang L and Zhou M: KLF5 interacts with p53 in regulating survivin
expression in acute lymphoblastic leukemia. J Biol Chem.
281:14711–14718. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Y, Hamza MS, Leong HS, Lim CB, Pan
YF, Cheung E, Soo KC and Iyer NG: Kruppel-like factor 5 modulates
p53-independent apoptosis through Pim1 survival kinase in cancer
cells. Oncogene. 27:1–8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen C, Zhou Z, Guo P and Dong JT:
Proteasomal degradation of the KLF5 transcription factor through a
ubiquitin-independent pathway. FEBS Lett. 581:1124–1130. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu N, Li H, Li S, Shen M, Xiao N, Chen Y,
Wang Y, Wang W, Wang R, Wang Q, et al: The Fbw7/human CDC4 tumor
suppressor targets proproliferative factor KLF5 for ubiquitination
and degradation through multiple phosphodegron motifs. J Biol Chem.
285:18858–18867. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao D, Zheng HQ, Zhou Z and Chen C: The
Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated
degradation and suppresses breast cell proliferation. Cancer Res.
70:4728–4738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao D, Zhi X, Zhou Z and Chen C: TAZ
antagonizes the WWP1-mediated KLF5 degradation and promotes breast
cell proliferation and tumorigenesis. Carcinogenesis. 33:59–67.
2012. View Article : Google Scholar : PubMed/NCBI
|
